Differentiated thyroid carcinomas are the most frequent endocrine neoplasms, but account for few cancer-related deaths. Although the indolent growth of these cancers correlates well with longevity, the biological basis for this good prognosis is not known. In contrast, two of the most frequent autoimmune diseases involve the thyroid suggesting a high propensity for this organ to invoke destructive immunity. Unfortunately, the mechanism linking malignancy and autoimmunity is not clear, although the expression of the oncogenic fusion protein RET/PTC3 (RP3) in both of these disorders may provide a clue. Interestingly, the signaling caused by activated RET kinase involves overlapping pathways and some common to the inflammatory response. Accordingly, we analyzed the function of RP3 and a mutant RP3 molecule to induce proinflammatory pathways in thyroid epithelial cells. Indeed, we find that RP3 alone causes increases in nuclear NF-jB activity and secretion of MCP-1 and GM-CSF. Finally, transfer of RP3-expressing thyrocytes into mice in vivo attracted dense macrophage infiltrates, which lead to rapid thyroid cell death. Further, cytokine synthesis and inflammation was largely abrogated by mutation of RP3 Tyr
Introduction
An association between papillary thyroid carcinoma and lymphocytic thyroiditis has been noted since the early 1950s (Crile and Fisher, 1953; Dailey et al., 1955) . This association was shown to correspond to a favorable clinical outcome in patients with infrequent tumor recurrence, more differentiated tumors and lower mortality rates (Matsubayashi et al., 1995; Loh et al., 1999; Tamimi, 2002) . While the origins of papillary thyroid carcinoma-associated lymphocytic thyroiditis are unknown, genetic analysis of papillary thyroid carcinomas has shown that specific chromosomal rearrangements of the RET/PTC gene family are prevalent (Jhiang, 2000) . The RET/PTC fusion protein family results from the joining of the amino-terminus of several fusion partners with the carboxyl-terminus of the tyrosine kinase, c-RET. One member of the RET/PTC family, RET/PTC3 (RP3), is composed of the aminoterminal portion of the androgen receptor-associated protein, ARA70, and the carboxyl-terminal portion of c-RET (Santoro et al., 1994) . Like other members of this oncogene family, the tumorigenic function of RP3 is attributed to the constitutive activity of the kinase domain derived from c-RET and the activation of the downstream signaling pathways (Jhiang, 2000; Manie et al., 2001; Takahashi, 2001) .
The expression of one or more RET/PTC oncogene family members has been reported in a majority of papillary thyroid carcinomas particularly at early stages of neoplastic progression. Indeed, RET/PTC expression was more likely to be found in occult or microcarcinomas of the thyroid than in poorly differentiated thyroid carcinomas, suggesting that RET/PTC activation is an early event in thyroid transformation (Viglietto et al., 1995; Bongarzone et al., 1996; Sugg et al., 1998; Fusco et al., 2002) . Interestingly, RET/PTC expression has been frequently observed in patients afflicted with papillary thyroid carcinomas associated with autoimmune thyroiditis (Wirtschafter et al., 1997; Di Pasquale et al., 2001; Mechler et al., 2001) and in those patients with autoimmune thyroiditis but no pathologically detectable carcinoma (Wirtschafter et al., 1997; Sheils et al., 2000) . Furthermore, patients diagnosed with autoimmune thyroiditis stained for c-RET protein, indicating that these specimens may express either an oncogenic RET/PTC family member or the protooncogene, c-RET, in thyroid epithelial cells (Di Pasquale et al., 2001) . Consistent with a contributory role of RET/PTC in cancer-associated inflammation, transgenic mice engineered to express RET/PTC in the thyroid show leukocytic infiltration (Jhiang et al., 1996; Santoro et al., 1996) . Inflammation, although evident, does not develop into clinically detectable autoimmune disease and therefore, other components are likely required before chronic inflammation ensues. The association of RET/PTC with thyroiditis suggests that RET/PTC oncoprotein expression may be one component important for thyroid-specific inflammation. Since RET/PTC functions as an oncogene, this combined proinflammatory feature may influence tumor progression.
There are numerous examples of constitutive proinflammatory cytokine expression by cell lines established from differentiated or undifferentiated thyroid carcinomas (Enomoto et al., 1990; Kennedy et al., 1992; Yoshida et al., 1994; Fiore et al., 1997; Kurebayashi et al., 2000; Basolo et al., 2002) . Specifically, tumor tissue or tumor-derived cell lines from differentiated carcinomas secrete G-CSF, GM-CSF, IL-1a, IL-6, IL-8, MCP-1 and/or TNF-a (Tohyama et al., 1992; Kayser et al., 1995 Kayser et al., , 1996 Nakada et al., 1996; Basolo et al., 1998; Kurebayashi et al., 2000; Scarpino et al., 2000) , whereas undifferentiated thyroid carcinomas have been shown to produce the cytokines GROa, G-CSF, GM-CSF and IL-1a, IL-6, IL-8 and/or TNF-a (Enomoto et al., 1990; Yoshida et al., 1992 Yoshida et al., , 1994 Aust et al., 1996 Aust et al., , 2001 Basolo et al., 1998; Asakawa and Kobayashi, 1999) . Moreover, the cell lines known to express an activated form of c-RET express the cytokines IL-6 and IL-8, suggesting that c-RET activation may directly signal cytokine expression (Basolo et al., 2002; Iwahashi et al., 2002) .
However, while thyroid carcinomas are associated with the constitutive expression of several proinflammatory cytokines and differentiated thyroid carcinomas are promoted by RET/PTC expression, no mechanistic connection has been made between RET/PTC expression and the activation of proinflammatory cytokine gene transcription/translation. The tyrosine kinase of c-RET, upon activation, phosphorylates specific tyrosine residues in its cytoplasmic domain; phospho-tyrosines are then bound by adaptor molecules and signals propagated to the nucleus (Takahashi, 2001) . Accordingly, phosphorylation of tyrosine 1062 of c-RET (tyrosine 588 of RP3) is critical for the attraction of adaptor proteins that allow signals to be sent through PI3K/AKT, p38MAPK, RAS/ERK and JNK (Hayashi et al., 2000) . RET/PTC fusion proteins contain tyrosine 1062 and may activate similar signaling pathways due to the constitutive activation of the c-RET-derived tyrosine kinase domain including the PI3K/AKT, p38MAPK, PLCg, RAS/ERK and JNK signaling pathways (Jhiang, 2000; Manie et al., 2001; Takahashi, 2001) . Moreover, active forms of c-RET have been shown to activate the transcription factor NF-kB (Visconti et al., 1997; Hayashi et al., 2000; Ludwig et al., 2001; Iwahashi et al., 2002) . NF-kB promotes the transcriptional activation of a number of target genes including many proinflammatory mediators and genes promoting cell survival (Ghosh and Karin, 2002) . Since RET kinase activity is frequently associated with PTC and can activate NF-kB, we aimed to examine the capacity of RP3 to directly mediate synthesis of proinflammatory cytokines when expressed in thyroid cells. Consequently, we hypothesized that RP3 through the production of cytokines may initiate the activation of innate immunity and leukocytic infiltration. The potential for RET/PTC-expressing thyroid cells to induce inflammatory mediators may provide insight into the role RET/PTC plays in thyroid tumor progression.
Results

RP3 expression induces GM-CSF and MCP-1 production by thyrocytes in vitro
To assess the capability of RP3 to activate inflammation, we investigated the direct effects of de novo RP3 expression in a thyrocyte cell line. Accordingly, the PC Cl3 rat thyrocyte cell line was transduced with recombinant retroviruses encoding RP3 or a mutant form of RP3 containing a Y to F amino-acid substitution at position 588 (RP3 Figure 1a ). To determine whether RP3 was capable of activating NF-kB in a manner analogous to RP1 (Visconti et al., 1997) , we performed EMSA on control-, RP3-, and RP3 Y588F -expressing cells. Consistent with previous studies of RP1, we observed a significant increase in NF-kB-binding activity in nuclear extracts from RP3-expressing thyrocytes compared to control cells and this induction was dependent on tyrosine 588 of the RP3 molecule (Figure 1b) .
In order to determine whether the increase in NF-kBbinding activity corresponded to an increase in proinflammatory cytokine expression, the expression of a panel of NF-kB-inducible cytokine genes was examined in RP3-expressing cells. For one, RT-PCR analysis revealed a substantial increase in the expression of the proinflammatory cytokines Kc/Groa, Mcp-1 and Gm-csf (Figure 2a and b) , whereas expression of Il-1a was evident, although in lower levels, and Il-1b and Tnf-a were not observed compared to the vector control cell line (data not shown). Biologically significant levels of cytokine protein were detected in culture supernatants from RP3-expressing but not control cells as determined by two independent assays (Figure 3a and b) . For example, an ELISA specific for rat MCP-1 revealed that RP3-expressing cells secreted 68 ng/ml (79 ng/ml) MCP-1 although none was detectable in control PC Cl3 (Figure 3a ). This level of MCP-1 synthesis is sufficient to induce macrophage expression of CD11b and activate cellular cytotoxicity (Biswas and Sodhi, 2002) . A second assay was used to measure the production of bioactive GM-CSF. Accordingly, serial dilutions of the culture supernatant from RP3-expres-sing, but not control cells, supported the growth of the FDC-P1 GM-CSF-dependent cell line (Figure 3b ).
An RP3 signaling-deficient mutant abrogates cytokine synthesis in expressing thyrocytes
The ability of RP1 to signal mitogenesis is strongly dependent upon the phosphorylation of tyrosine 451 (Tyr 1062 in c-RET and Tyr 588 in RP3) and the subsequent binding of SHC adaptor proteins (Chiariello et al., 1998; Salvatore et al., 2000) . Mutation of this tyrosine to phenylalanine can abrogate SHC binding and subsequent signaling through the JNK, RAS/MAPK and PI3 K pathways (Hayashi et al., 2000) . To test the requirement of Tyr 588 in RP3 to mediate signaling required for the production of inflammatory cytokines, an RP3 construct containing a tyrosine to phenylalanine mutation (Y588F) was transduced into PC Cl3 thyrocytes. The level of RP3 mRNA and protein expression was equal in RP3-and RET/PTC3 induces proinflammatory cytokines JP Russell et al
RP3 induces nonthyroid fibroblasts to express proinflammatory cytokines
In human, disease RET/PTC fusion proteins are restricted to thyroid epithelial cells, implying that RP3 activity may be dependent on thyrocytes for inflammatory function. To determine if the function of RP3 to induce proinflammatory cytokines is cell specific, we transduced the mouse fibroblast line, NIH-3T3, with an RP3 expression vector. Compared to vector-transduced controls, increased expression of Kc/Groa, Mcp-1 and Gm-csf was observed in RP3-expressing fibroblasts ( Figure 4 ). Similar to observations in RP3 Y588F -expressing thyrocytes, fibroblasts expressing RP3 Y588F produced Gm-csf and Kc/Groa, at levels comparable to controls, while Mcp-1 was partially induced compared to level of MCP1 in RP3-expressing fibroblasts (Figure 4 ).
RP3-expressing thyrocytes elicit an inflammatory response causing cell loss in vivo
The observation that RP3-expressing thyrocytes produce myeloid growth and chemotactic proteins, suggested that these cells may induce localized inflammation when transplanted into mice in vivo. Thus, to model the capability of RP3 to induce organ-specific inflammation, CFSE-labeled vector control, RP3-and RP3
Y588F
-expressing thyrocytes were subcutaneously injected into SCID mice. At 1, 3 and 7 days following cell transfer, injection sites were excised, examined histologically and the number of CSFE-labeled cells quantified. At 1 week following injection of control or RP3-expressing thyrocytes, small swellings or 'tumors' were observed in all the mice. Gross analysis of these lesions revealed a striking difference in angiogenic response between the groups with RP3-injected mice demonstrating numerous newly formed vessels (Figure 5a and b) . To ascertain the cellular nature of these lesions, injected regions were excised 3 days after injection and immunohistochemical analysis performed. Using an antibody specific for CD11b, we identified infiltrated cells as macrophages and in the same field observed CFSE-labeled thyrocytes by fluorescence (Figure 5c -f). Cellular infiltrates, for both control and RP3-expressing thyrocytes, were positive for the leukocytic markers CD11b, F4/80 and GR-1 (Figure5c and d and data not shown). Although leukocytic infiltrates were observed 24 h after injection of control, RP3 and RP3 Y588F groups, the loss of cells following infiltration occurred rapidly only in the RP3 group. The majority of RP3-expressing cells were eliminated by day 3, as measured by the reduction of CFSE-stained cells in comparison to RP3 Y588F and control cells (Figure 5e and f) which were still present in numbers similar to day 1 values. Furthermore, this leukocytic cytotoxicity was dependent on RP3 signaling, since cell loss in RP3
-injected mice leads to responses similar to vector controls (Figure 5g ).
Discussion
The longstanding clinical association between cancer and leukocytic inflammation is well described (Coussens Werb, 2002) . These findings are observed throughout a wide variety of malignancies, even though few studies have identified the specific molecular event(s) following cellular transformation that confer(s) the proinflammatory property of neoplastic tissue. We have investigated the link between inflammation and cancer in thyroid disease, since the expression of the novel oncogene RET/PTC was associated with cancer and, in some cases, autoimmune disease. These findings prompted us to hypothesize that one function of RP3 is to initiate innate immunity. Accordingly, we have examined RP3-expressing thyrocytes for their ability to secrete proinflammatory cytokines in vitro and signal leukocytic infiltration using an in vivo assay. In this study, we provide evidence that directed RP3 expression and signaling in cell lines in vitro causes transcription of the myeloid inflammatory mediators Gm-csf, Kc/Groa and Mcp-1. Moreover, we demonstrated that RP3 signaling in cells provides a strong inflammatory stimulus to the host immune system, as evidenced by leukocytic infiltration, primarily composed of macrophages, using an in vivo assay. This infiltration leads to the loss of significant numbers of RP3-expressing cells, but not control or RP3 mutant-expressing cells, suggesting that innate inflammation may place selection pressure on only transformed cells. Previous work in the field has illustrated that the oncogenic properties of the RET/PTC fusion proteins are derived from the constitutive activation of the tyrosine kinase domain (Jhiang, 2000) . Important for our studies was the finding that c-RET, as well as oncogenic forms of c-RET, RET/PTC fusion proteins and those found associated with MEN2, can activate NF-kB (Visconti et al., 1997; Hayashi et al., 2000; Ludwig et al., 2001) . Functionally, this pathway was required for RET-induced oncogenesis (Karin and Lin, 2002) . Although NF-kB activity can promote cell growth, NF-kB activity also promotes the transcription of many proinflammatory cytokines (Foo and Nolan, 1999) . We reasoned that this property of NF-kB may be activated by the function of RET/PTC fusion proteins and cause proinflammatory cytokine transcription. Y588F expressing (white bars) cells reveals a significant decrease in the number of RP3-expressing cells compared to control (*P o0.04) or RP3 mutant cells (Po0.004), as measured 3 days after injection into SCID mice. The number of RP3 Y588F cells 3 days after transfer is not significantly different from control (**P ¼ 0.9). There is no significant difference in cell number between the groups at day 1 (P40.35). Data are from five to nine independent experiments RET/PTC3 induces proinflammatory cytokines JP Russell et al Consistent with this idea, we find that nuclear extracts from RP3-expressing thyrocytes had increased NF-kBbinding activity compared to controls. Moreover, this binding activity was coordinated with increased expression of selected cytokines in thyrocytes and fibroblasts. Since the dimerized intracellular domain of c-RET is largely responsible for the signaling following ligand binding, we were interested in determining if the induction of cytokine synthesis could be directly linked to signaling caused by RP3 in the absence of ligand. Indeed, mutation of Tyr 588 within RP3 prevented the transcription of Kc/Groa and Gm-csf, demonstrating the importance of this tyrosine and downstream signaling pathways in RP3-expressing cells. Although expression of RET/PTC fusion proteins appears restricted to thyroid epithelium in human disease, the ability of RP3 to induce cytokine transcription was not cell-type restricted, since RP3-expressing fibroblasts also produced cytokine mRNA and protein; a property also dependent on Tyr
588
. Therefore, the ectopic expression of the RP3 oncoprotein not only promotes cellular transformation , but also induces the secretion of cytokines known to promote and sustain inflammation.
Experiments designed to assess a specific set of cytokines produced by RP3-transfected thyrocytes identified GM-CSF and MCP-1 as the predominant mediators. While the function of these mediators to promote localized inflammation is well known, we show evidence that, in this system, the process is dependent on the activity of the RP3 oncogene. These cells exhibited a strong proinflammatory function in vivo, suggesting that a similar process may occur in the microenvironment of RET kinase-expressing thyroid epithelium. Consistent with this, two independently derived RP1 transgenic mouse strains reported inflammatory reactions within the thyroid (Santoro et al., 1996; Sagartz et al., 1997) . In addition, RP3-expressing mouse thyroid tumors transplanted into RP3-primed mice induce extensive leukocytic infiltration (Powell et al., 2002) . These leukocytes may be critical to the disease process, since macrophages and dendritic cells are frequently present in diseased organs (Kabel et al., 1987) . Accordingly, RP3-induced cytokines may be responsible for the attraction and stimulation of antigen-presenting cells. Indeed, due to their ability to attract and activate leukocytes, GM-CSF and MCP-1 have been employed as adjuvants in immunotherapeutic treatment of cancer (Wang et al., 1998; Borrello and Pardoll, 2002) . Specifically, GM-CSF has been used in clinical trials to activate antitumor immunity in melanoma patients, as a method to activate dendritic cells and enable tumor antigen presentation to tumor-specific CD4 þ and CD8 þ T cells (Borrello and Pardoll, 2002) . The reasons for this rapid elimination of RP3-expressing thyrocytes are not yet clear; however, these data suggest a separate mechanism through which RP3 may activate thyroid cells to incite macrophage cytotoxic functions in vivo. Nevertheless, the RP3-induced factors likely contribute to this phenomenon since MCP-1 alone is known to induce macrophage chemotaxis, the upregulation of CD11b and macrophage cytotoxicity (Biswas and Sodhi, 2002) . Although the vector control and RP3 Y588F cells induced 'background' inflammation in this assay, we were able to distinguish a clear phenotypic difference between RP3 and the other groups. Indeed, numerous RP3-expressing cells were lost to a significantly greater extent than the RP3 Y588F or control groups, suggesting that additional (procytotoxic) RP3-induced thyrocyte signals may be received by the infiltrated cells.
These data point to a testable model explaining the association of an activated form of the RET kinase in the thyroids of patients with cancer and thyroiditis. In this model (Figure 6 ), activated c-RET kinase is derived from the dimerization of the RP3 molecule. c-RET kinase activation would then trigger the phosphorylation of key tyrosine residues within the intracellular domain of c-RET, adaptor protein binding, NF-kB activation and subsequent cytokine synthesis. Chronic cytokine synthesis of molecules such as GM-CSF and MCP-1 initiates innate immune infiltration into the thyroid attracting CD11b þ , F4/80 þ myeloid cells. Subsequent lymphoid infiltration resulting from additional lymphokine and chemokine synthesis may lead to tissue-specific antigen presentation, thus provoking Tcell responses. The combination of lymphoid and myeloid infiltration along with cellular activation would potentially lead to a chronic inflammatory state. Although the direct effects of leukocytes or cytokines may include thyroid cell death, we propose that some cells may survive this onslaught due to pre-existing mutations or adaptive responses, and therefore sustain the inflammation and, in rarer instances, support the progression to cancer in predisposed individuals through additional selection mechanisms by the adaptive immune responses (Daniel et al., 2003) . Although RET/PTC somatic gene alterations are functionally important for the development of thyroid malignancy (Jhiang, 2000) , the data herein suggest that they may also be causally related to inflammation. This hypothesis is supported by the direct production of proinflammatory cytokines by RP3-expressing thyrocytes, the appearance of inflammatory cells in RP1 and RP3 transgenic thyroids (Jhiang et al., 1996; Santoro et al., 1996) , the rejection of transplanted RP3-expressing thyroid tumors in syngeneic mice (Powell et al., 2001 ) and the immunogenicity of RP3 protein (Powell et al., 2002) . RET/PTC fusion proteins, like RP3, may be directly responsible for provoking the chronic inflammatory disease coincident with cancer in thyroid disease patients. This is of particular interest since the frequency of thyroiditis in thyroid cancer is approximately 30% (Braverman and Utiger, 1995; Kebebew et al., 2001) and can be as high as 50% in some patients (Tamimi, 2002) . Furthermore, thyroiditis may become a common malady as we age, since an estimated 6.6% of autopsies show pathological evidence of thyroiditis in normal (euthyroid) individuals (Fleischmann and Hardmeier, 1999) . Thus, the studies described herein support a model whereby RET/PTC-induced thyroid neoplastic progression is influenced not only by the oncogenic properties of the fusion protein (growth, survival, apoptosis), but also by the inflammatory response made up of macrophages attracted to the thyroid by the constitutive activation of the RET kinase. Although we do not yet understand how this interaction may determine the fate of RET/PTC-expressing thyroid tissue, environmental factors, HLA predisposition, and undefined stochastic processes may conspire to control progression of these early lesions to promote carcinoma or chronic inflammation (Hanahan and Weinberg, 2000) .
The elucidation of the mechanism underlying the connection between RET/PTC expression, cytokine secretion and inflammation may facilitate the development of antagonists of RET/PTC that would alleviate the autoimmune effects of chronic inflammation or agonists to encourage the antitumor effects of cancerassociated inflammation, thus mitigating thyroid dysfunction. Along these lines, the potency of the Tyr 588 -mediated signaling in inducing the cytokine response points to a potential therapeutic target in modulating thyroid disease.
Materials and methods
Cell culture
PC Cl3 rat thyrocytes were obtained from Dr Jeffrey Knauf (University of Cincinnati, Cincinnati, OH, USA). The human RP3 oncogene was ligated into the retroviral vector, pMV7, to create RP3/pMV7 (Santoro et al., 1994) . Tyr 588 (Tyr 1062 of c-RET) of the RP3/pMV7 construct was mutated with the QuikChange Mutagenesis Kit (Stratagene, La Jolla, CA, USA) to a phenylalanine to create RP3 Y588F /pMV7. The existence of the Y588F mutation in RP3 was confirmed by DNA sequencing (data not shown). The constructed vectors were then transfected into Phoenix cells (Garry Nolan, Stanford University School of Medicine), a MMLV packaging cell line, to produce recombinant retrovirus. PC Cl3 rat thyroid cells and NIH-3T3 mouse fibroblasts were infected with the recombinant retroviruses and selected in media containing 400 mg/ml of G418. PC Cl3 rat thyroid cells were grown in Coon's modified F12 medium (Sigma, St Louis, MO, USA) supplemented with 5% FBS, 100 U/ml penicillin/streptomycin, 2 mm l-glutamine and the following growth factors. 10 ng/ml somatostatin, 10 ng/ml glucine-histidine-lysine, 5 mg/ml transferrin, 10 nm hydrocortisone, 10 mg/ml insulin and 10 mIU/ml bovine thyroid-stimulating hormone. NIH-3T3 cells were grown in Dulbecco's modified Eagle's media with 5% FBS and 100 U/ml penicillin/streptomycin. Phoenix cells were grown in Dulbecco's modified Eagle's media with 10% FBS and 100 U/ml penicillin/streptomycin. A rabbit polyclonal antibody to human c-RET was provided by Dr Santoro or obtained from Santa Cruz Biotechnology (C-19), Santa Cruz, CA, USA. For cytokine controls, NR8383 rat alveolar macrophage cells (ATCC) were cultured in HAMF1 medium supplemented with 15% FCS and 100 U/ml penicillin/streptomycin. NR8383 cells were incubated with 10 ng/ml LPS (from S. enteritidis, SIGMA Chemical Co., lot # 59F4002) for 24 h prior to extraction of RNA.
RT-PCR analysis
Transduced PC Cl3 thyrocytes were homogenized in 0.5 ml of cell lysis buffer (4 m guanidinium thyiocyanate, 25 mm sodium citrate, 0.5% sodium N-lauroylsarcosine, 0.1 m 2-mercaptoethanol). RNA was extracted using phenol : chloroform (1 : 1) and ethanol. Precipitated DNA was digested using RNAse free DNAse (Ambion, Austin, TX, USA). DNAsedigested total RNA (5 mg) was reverse transcribed with Superscript II (Invitrogen, Carlsbad, CA, USA) to create cDNA which was amplified by PCR using primers specific for glyceraldehyde-3-phosphate dehydrogenase (G3pdh) for normalization of cytokine-specific primers. Optimal quantitative cycling conditions for each primer set were determined by first plotting product amounts (represented as band volumes measured by densitometric analysis) at five cycle intervals over the range of 20-45 cycles. PCR cycling conditions consisted of denaturation at 941C for 4 min for 1 cycle, followed by 20-45 cycles of denaturation (941C for 30 s), primer annealing (601C for 30 s), extension (721C for 60 s) and a final single extension cycle of 721C for 7 min. PCR cycle number was plotted versus band intensity for each primer set and the linear portion of the curve determined the optimal number of cycles. For all specimens, PCR reactions were performed using this optimized cycle number. The optimal cycling conditions for the G3pdh primer set was determined to be 25 cycles, while all other primer sets were determined to be optimal at 30 cycles. The primers specific for rat G3pdh 0 primer were used CTTT-CAGCATCTTCACGG). The sizes of the PCR products generated were: G3pdh, 100 bp; Il-1a, 172 bp; Il-1b, 513 bp; Mcp-1, 320 bp; Tnf-a, 281 bp; rGm-csf, 259 bp; rKc, 371 bp; RP3, 310 bp. Negative control PCR reactions were performed utilizing cDNA from sham reverse-transcribed RNA. PCR reactions were electrophoresed in 2% agarose gels with 0.5 mg/ml of EtBr and quantified using the BioRad Gel Doc and Quantity One program (BioRad, Hercules, CA, USA). Background gel luminosity was subtracted and band luminosities were normalized according to values obtained for G3pdh PCR.
Electrophoretic mobility shift assay (EMSA)
Nuclear extracts were prepared by the method of Dignam et al. (1983) . NF-kB activity was assessed in a 20 ml binding reaction containing 3 mg nuclear extract, 10 mm HEPES (pH 7.9), 50 mm KCl, 0.1 mm EDTA, 2.5 mm DTT, 10% glycerol and 0.05% NP-40. A 50 Â fold excess (9 pmol) of unlabeled NF-kB or nonspecific oligonucleotide was added, when indicated, and incubated for 15 min at 251C. Labeled NF-kB oligonucleotide (0.175 pmol) was added to each reaction and incubated for 15 min at 251C. Protein-DNA complexes were resolved on a 5% TBE acrylamide gel for 1.5 h at 300 V in 0.5 Â TBE buffer. Gels were transferred, dried and imaged using a Molecular Dynamics Phosphorimager (Molecular Dynamics, Sunnyvale, CA, USA).
Western blot analysis
Tissues were homogenized, and cell lysates prepared in protein extract buffer (30 mm Tris-HCl (pH 8.0), 10 mm EDTA, 1% Triton X-100, 100 mm NaCl, 1 mm phenylmethylsulfonyl fluoride) and stored at -701C. Proteins were separated by SDS-PAGE and transferred to a nitrocellulose membrane. Membranes were blocked for 30 min in TBST buffer (20 mm Tris-HCl (pH 7.6), 135 mm NaCl, 1% Tween 20) with 5% BSA and immunoblotted with rabbit anti-RET antisera (Dr Santoro) for 16 h at 41C. Following incubation, membranes were washed three times for 5 min in TBST buffer and treated with horseradish peroxidase-conjugated donkey anti-rabbit IgG (Amersham, Piscataway, NJ, USA) 1 h at room temperature. Membranes were washed, and the protein bands visualized using ECL (Amersham) after exposure to X-ray film for 1-5 min.
ELISA MCP-1 was measured by ELISA according to the instructions by the manufacturer (Amersham). pMV7-, RP3-and RP3 Y588F -expressing thyrocytes were grown to confluency and the culture media were collected and filtered before use in ELISA. All values refer to the average of duplicate samples 7s.e.m.
Proliferation assay
The presence of GM-CSF secreted by transduced thyrocytes was detected using a functional assay by measuring the proliferation of the GM-CSF-dependent cell line, FDC-P1.
Supernatants from confluent flasks of pMV7-, RP3-and RP3
Y588F
-expressing thyrocytes were filtered and serially diluted into a 96-well plate to which 2 Â 10 4 FDC-P1 cells/ well were added in a total volume of 200 ml. The cells were incubated for 48 h at 371C, pulsed with 1 mCi [ 3 H] thymidine/ well for 6 h, harvested and cell-incorporated radioactivity was detected after harvesting cells on glass fiber filters. Reported values are the mean incorporated radioactivity for triplicate wells and standard error of that mean.
Transplantation of thyroid cell transfectants in vivo
Control, RP3-and RP3
Y588F
-expressing PC Cl3 rat thyrocytes were trypsinized, washed 2 Â in PBS and labeled with CFSE (Molecular Probes, Inc., Eugene, OR, USA) for 15 min at 371C. Cells were then resuspended with an equal volume of FBS, washed 3 Â in PBS and counted. Labeled thyrocytes (2 Â 10 6 ) were resuspended in 100 ml of PBS and injected intradermally. Resection of thyrocytes occurred at 1, 3 and 7 days after injection. Tissue was placed in tissue freezing media (Fisher Scientific, Pittsburgh, PA, USA) and frozen in liquid nitrogen. Serial sections (6 mm) were dried for 1 h, fixed in icecold acetone for 20 min, allowed to dry for 2 h and then stored at À201C until use. Sections were thawed, refixed in cold acetone for 5 min and then allowed to air dry for 10 min. Sections were then hydrated in PBS, treated with 0.3% H 2 O 2 , blocked with 0.1% BSA/PBS for 5 min and 10% normal serum for 15 min. Primary antibody was incubated on sections for 1 h at 251C. Frozen sections were stained with the following antibodies at a dilution of 1 : 100: 500 mg/ml CD11b, 500 mg/ml Ly-6G (Gr-1), 500 mg/ml rat IgG 2b (Pharmingen, San Diego, CA, USA), 200 mg/ml F4/80 (Caltag, Burlingame, CA, USA). Slides were washed for 5 min, two times, with PBS, once with 0.1% BSA/PBS and incubated with biotin-labeled secondary antibody for 1 h at 251C. Slides were washed as above and incubated with substrate according to the DAB Vectastain kit (Vector Labs, Burlingame, CA, USA). Tissues were then counterstained with hematoxylin, dehydrated and mounted. Sections were visualized using fluoresence microscopy and images recorded using digital microscopy. Images were converted to grayscale and the number of labeled thyrocytes scanned using colony-counting software (BioRad, Hercules, CA, USA). A minimum of four sections were visualized at each time point and data are reported as the average number of CFSE-labeled thyrocytes 7s.e.m.
Statistical analysis
Results are presented as the mean 7s.e. m. The data were analysed using the Analyse-it software program for Microsoft Excel by the Student's t-test. P-values o0.05 were considered statistically significant.
